P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma

Sagar Lonial, Jesus G Berdeja, Meletios-Athanasios Dimopoulos, Sundar Jagannath, Stefan Knop, Hang Quach, Paula Rodríguez-Otero, Paul G Richardson, April Sorrell, Min Chen, Elisabeth Kueenburg, Tuong Vi Nguyen, Kevin Hong, Teresa Peluso, Niels WCJ van de Donk